• 萬維書刊網微信二維碼

    掃微信,關注編輯QQ!

    您的位置:萬維書刊網 >>sci/e期刊大全 >>醫藥衛生3>>行為科學
    您的位置:萬維書刊網 >>ssci期刊 >>心理學類>>發展心理學

    AUTISM RESEARCH《自閉癥研究》 (官網投稿)

    簡介
    • 期刊簡稱AUTISM RES
    • 參考譯名《自閉癥研究》
    • 核心類別 SCI期刊(2019), SCIE期刊(2019), SSCI期刊(2019), 外文期刊,
    • IF影響因子3.697(2018年) 3.768(2017年) 3.765(2016年) 3.048(2015年) 4.330(2014年) 4.532(2013年) 3.988 (2012年) 3.686(2011年)
    • 自引率9.50%
    • 主要研究方向醫學-行為科學;PSYCHOLOGY, DEVELOPMENTAL 發展心理學

    主要研究方向:

    等待設置主要研究方向
    醫學-行為科學;PSYCHOLOGY, DEVELOPMENTAL 發展心理學

    AUTISM RESEARCH《自閉癥研究》(月刊),雜志涵蓋與自閉癥譜系障礙(ASD)和緊密相關的神經發育障礙有關的研究。該雜志重點介紹基本的遺傳,神經生物學和心理機制,以及這些機制如何影響ASD的發展過程。該雜志鼓勵提交對自閉癥的生物學和心理學采取發展方法的研究文章。
    征稿信息

    萬維提示:

    1、投稿方式:在線投稿。

    2、期刊網址:

    https://onlinelibrary.wiley.com/journal/19393806

    3、投稿網址:

    https://mc.manuscriptcentral.com/autismresearch

    4、官網郵箱:autismres@wiley.com

    aurprod@wiley.com

    5、期刊刊期:月刊,一年出版12期。

    2020年1211日星期

                                      


    投稿須知【官網信息】

     

    Author Guidelines

    1. SUBMISSION

    Authors should note that submission implies that the content has not been published or submitted for publication elsewhere except possibly as a brief abstract in the proceedings of a scientific meeting or symposium. If there is a related paper under consideration at another journal, the corresponding author should inform the Editor in the cover letter and a copy of that paper should be submitted with the primary manuscript as supporting information.

    Authors should follow the guidelines carefully; failure to do so will delay the processing of the manuscript. Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at manuscriptcentral.com/autismresearch. Authors unfamiliar with ScholarOne can find details on how to use the system here: www.wileyauthors.com/scholarone.

    The submission system will prompt authors to use an ORCID iD (a unique author identifier) to help distinguish their work from that of other researchers. Details can be found elsewhere in these guidelines.

    Autism Research will consider submissions that have previously been made available online, either on a preprint server like arXiv, bioRxiv, or PeerJ PrePrints, or on the authors’ own website. However, any such submissions must not have been published in a scientific journal, book or other venue that could be considered formal publication. Authors must inform the editorial office at submission if their paper has been made available as a preprint.

    Authors of accepted papers that were made available as preprints must be able to assign copyright to Autism Research, or agree to the terms of the Wiley Open Access agreement and pay the associated fee

    Given that the measurable impact of the article is diminished when citations are split between the preprint and the published article, authors are required to:

    Update the entry on the preprint server so that it links to and cites the DOI for the published version

    Cite only the published article themselves

    By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

    For help with submissions, please contact the Editorial Office: autismres@wiley.com. When necessary, the Editorial Office staff may refer questions to the Editor-in-Chief or Associate Editors.

    2. AIMS AND SCOPE

    Autism Research is owned and supported by The International Society for Autism Research (INSAR), a scientific and professional organization devoted to advancing knowledge about Autism Spectrum Disorder (ASD). For more information, please visit the Society Information section of the journal homepage.

    Autism Research covers research relevant to ASD and closely related neurodevelopmental disorders. The journal focuses on genetic, neurobiological, immunological, epidemiological and psychological mechanisms and how these influence developmental processes in ASD. The journal encourages the submission of original research papers (Research Articles and Short Reports) that take a developmental approach to the biology and psychology of autism, with a particular emphasis on identifying underlying mechanisms and integrating across different levels of analysis. Contributions are typically empirical, but the journal also publishes theoretical papers if they significantly advance thinking. The journal encourages papers reporting work on animals or cell or other model systems that are directly relevant to a better understanding of ASD. Please note that the journal does not publish manuscripts of human research that are based soley on a neurotypical population. The journal also publishes reports of carefully conducted clinical trials of treatments for the core symptoms or one of the common co-morbid symptoms of ASD. Papers presenting clinical trials will be judged, in part, on whether there is an empirical justification for the reported treatment. Individuals included in research studies can span the full spectrum of ASD, including the broader phenotype, and there are no restrictions on study participants in terms of age or intellectual ability.

    3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

    Autism Research publishes the following contribution types:

    Research Articles

    Short Reports

    Review Articles

    Commentaries

    Letter to the Editor

    Manuscripts should be prepared according to the descriptions below. Submissions that do not conform to one of the descriptions below will be returned to the author.

    1. Research Articles.

    The text of these articles should include a scientific Abstract (150–250 words), a Lay Summary (see details elsewhere), and they should follow the IMRaD guidelines (Introduction, Methods, Results, and Discussion), which are recommended by the International Committee of Medical Journal Editors (ICMJE) (J. Pharmacol. Pharmacother. 2010, 1, 42–58). Manuscripts should be a maximum of 5,000 words in length (excluding Abstracts and References). If there are extenuating circumstances that require an increased length, authors should contact the Editorial Office with specific details and rationale for the Editor-in-Chief’s consideration.

    2. Short Reports.

    These are original research articles that report a well-conducted preliminary study or a novel finding of high potential impact. Typically these articles should not exceed 2,000 words in length (excluding Abstracts and References). The text of these articles should include a scientific Abstract (150–250 words), a Lay Summary (see details elsewhere), and while subsection headings are not specifically required, the flow of text should follow the IMRaD guidelines (Introduction, Methods, Results, and Discussion), which are recommended by the International Committee of Medical Journal Editors (ICMJE) (J. Pharmacol. Pharmacother. 2010, 1, 42–58).

    3. Review Articles.

    Review Articles are generally invited. However, authors are encouraged to contact the Editor-in-Chief if they are interested in preparing a Review on a timely topic that has not recently been covered by the journal. Permission of the Editor-in-Chief must be obtained prior to submission of a Review Article. Potential authors should send an e-mail to the Editor-in-Chief (dgamaral@ucdavis.edu) explaining the scope of the review and why it is timely to publish a review article on this topic at this time. If other similar review articles have appeared in other journals, the authors should explain what is different about the proposed article. Importantly, one or more of the authors should provide evidence that they have primary research experience in the topic by submitting a list of research papers related to the topic on which they are first or senior author.

    Review Articles are typically up to 8,000 words in length (excluding Abstracts and References).

    Review Articles should be accompanied by an Abstract of (150–250 words) and a Lay Summary (see details elsewhere). The manuscript can be organized as the authors wish, but should be logically structured to ensure readability.

    4. Commentaries.

    These are short articles (1500–3,000 words in length excluding Abstract and References) that are intended to 1) draw attention to developments or needs in a specific area of research, 2) bring together observations that point the field in a new direction, 3) give the authors’ personal views on a controversial topic, or 4) direct well-reasoned and substantive criticism of some widely held theoretical view or widely used technique or practice. Commentaries may also provide a historical perspective on an area of autism research. Authors should make their Commentary understandable to a broad readership. As with all other contribution types, they should have an Abstract of (150–250 words) and a Lay Summary (see details elsewhere).

    Potential authors are invited to submit a letter of interest to the Editor-in-Chief indicating the topic of a potential Commentary. The letter should also contain an outline of the contents and a brief statement on why it is a good time to review the topic in question. Commentaries will not be accepted for editorial processing unless pre-approved for submission.

    5. Letters to the Editor.

    From time to time, readers respond to an article published in Autism Research by writing a Letter to the Editor. Such letters may further the scientific discussion and provide meaningful context to the published work. Letters to the Editor do not have either an Abstract or a Lay Summary; they only have a few citations (always less than five) and those should be limited to the article in question and highly relevant references in support of the discourse. These contributions should be short (usually 300 words or less). They should be written in continuous prose without subsections. Letters to the Editor are only published after full consultation with the Editor-in-Chief, and if necessary the authors and/or reviewers of the published contribution under discussion. Authors wishing to publish a Letter to the Editor should first contact the Editor-in-Chief via email (autismres@wiley.com), prior to formal submission of the manuscript, to ensure the intended manuscript meets the requirements of this contribution type.

    4. PREPARING THE SUBMISSION

    Cover Letters

    During the submission process, authors will have the opportunity to provide a cover letter directly in a text field of the submission questionnaire within ScholarOne. Therein, details of any invitation received, any information pertinent to the submission, etc. should be provided. Authors wishing to upload a separate cover letter together with the submission files may do so, though this is not required.

    Parts of the Manuscript

    The submission should be uploaded in separate files: 1) manuscript main text file; 2) figures; 3) Supporting Information file(s).

    1. Manuscript Main Text File

    The text file should contain all of the manuscript text, including the tables and figure legends. The text should be presented in the following order:

    Title

    A short running title of less than 40 characters

    The full names of all authors

    The authors' institutional affiliations where the work was conducted, with a footnote for an author’s present address if different to where the work was carried out

    Acknowledgments

    Lay Summary

    Abstract and Keywords

    Main text

    References

    Tables (each table complete with title and footnotes)

    Figure legends

    Title

    The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations (see Wiley's best practice SEO tips).

    Authorship

    For details on eligibility for author listing, please refer to the journal’s Authorship policy outlined in Section 5 of these Author Guidelines.

    Acknowledgments

    Contributions from individuals who do not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

    Conflict of Interest Statement

    Authors will be asked to provide a conflict of interest statement during the submission process. See the journal’s policy on Conflict of Interest outlined in Section 5 of these Author Guidelines. Authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

    Abstract

    Please provide an abstract of 150–250 words containing the major keywords (see below). The abstract must be written in complete sentences. It should concisely state the questions addressed, the methods used, the main results and their significance. Importantly, the abstract should stand alone without references and with abbreviations appropriately defined. Note, the Abstract should not be structured; please do not include line breaks or paragraph headings.

    Lay Summary

    Autism Research and INSAR are committed to making scientific research accessible to both the scientific and non-scientific communities. In an effort to do this, since the journal’s launch, authors have provided lay summaries intended to inform the non-scientific community of important findings. In a continuing effort to refine this policy, each author is asked to provide an Lay Summary.

    A brief statement of 2-3 sentences (60–80 words; 300–500 characters including spaces) included at the end of the Abstract that summarizes the impact/importance/relevance/key findings of the study. The Lay Summary should be aimed at interested persons without a scientific background.

    Authors are encouraged to use a readability analyzer to evaluate the accessibility of their Lay Summary to non-scientists. Free online analyzers such as https://datayze.com/readability-analyzer.php provide an indication of the reading level of a given text.

    An article’s Lay Summary appears immediately below the Abstract and appears together with the Abstract on Wiley Online Library, as well as in Abstract & Indexing services that cover the journal, such as PubMed. This ensures that the Lay Summary is available to any reader free of charge at the article level rather than the issue level.

    Since its launch, Autism Research has sought to make scientific research accessible to non-scientists, particularly families with ASD. Like While the way in which the journal provides these lay abstracts has evolved over time, they are archived in a dedicated Special Features section of the journal’s website: www.autismresearchjournal.com.

    Keywords

    Please provide five to seven keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.

    Main Text

    The text should be divided as outlined in Section 3 “Manuscript Categories and Requirements”.

    Manuscripts reporting original research should follow the IMRaD guidelines (Introduction, Methods, Results, and Discussion), which are recommended by the International Committee of Medical Journal Editors (ICMJE) (J. Pharmacol. Pharmacother. 2010, 1, 42–58).

    The journal uses US spelling. Authors may submit using any form of English as the spelling of accepted papers is converted to US English during the production process.

    Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

    Authors for whom English is not their first language are encouraged to seek assistance from a native or fluent English speaker to proof read the manuscript prior to submission. Wiley offers a paid service that provides expert help in English language editing – further details are given below.

    Articles reporting data taken from or deposited elsewhere should refer to the journal policy on Data Storage and Documentation in Section 5 (below).

    ……


    投稿問答最小化  關閉

    很黄很黄的曰批视频 - 视频 - 在线观看 - 影视资讯 - 品赏网